IB

IASO BioTherapeutics(驯鹿生物)

Request removal

IASO Bio is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and autoimmune diseases. Leveraging its proprietary fully human antibody discovery platform (IMARS), high-throughput CAR-T drug priority platform, and proprietary manufacturing processes, IASO Bio is developing a rich clinical-stage pipeline of multiple autologous and allogeneic CAR-T and biologics product candidates. This includes a diversified portfolio of 8 novel pipeline products, as well as IASO's leading asset, CT103A, an innovative anti-BCMA CAR-T cell therapy under pivotal study for relapsed/refractory (R/R) multiple myeloma (RRMM), which was granted Breakthrough Therapeutic Designation by China's National Medical Products Administration (NMPA) in February 2021. In addition. The company's in-house developed fully human CD19/CD22 dual-targeted chimeric antigen receptor (CAR)-T cell therapy, has received two IND clearances from NMPA for the treatment of CD19/CD22-positive relapsed/refractory B-cell non-Hodgkin's lymphoma (r/r B-NHL) and relapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) in July 2021. For more information on IASO Bio, please visit www.iasobio.com.

Get valid emails for people working at IASO BioTherapeutics(驯鹿生物) and 200M other companies
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
IASO BioTherapeutics(驯鹿生物)'s headquarter address
Line 1: shanghai, shanghai, china
IASO BioTherapeutics(驯鹿生物)'s industries
research
IASO BioTherapeutics(驯鹿生物)'s technology
Microsoft Office 365 Viewpoint
People working at IASO BioTherapeutics(驯鹿生物)
DH
DONGGOU(David) HE,M.D.,Ph.D.
Executive Vice President and CTO
Shanghai, Shanghai, China
DL
Daofeng Liu
VP and site head, R&D, platform development
Shanghai, Shanghai, China
AF
Alan Fu
Chief Financial Officer
WP
Wen Wang, M.D., Ph.D.
Chief Executive Officer
Shanghai, Shanghai, China
CM
Claire Shelby, MD, MS
Sr. Director, Clinical Operations
Shanghai, Shanghai, China
YP
Yan Wang, M.D., Ph.D.
Executive Director of Business Development
Shanghai, Shanghai, China
GH
Guang Hu
Executive Director
Shanghai, Shanghai, China
YY
Yongkun Yang
R&D Director
JG
Jigang Guo
R&D Director
Shanghai, Shanghai, China
MZ
Mu Zhang
Sr. Scientist
Shanghai, Shanghai, China
You can find 32 people working at IASO BioTherapeutics(驯鹿生物) on FinalScout. Create a free account to view details including email addresses.
Scrape emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory